MEPs to vote on changes to key EU pharma regulation
This article was originally published in SRA
Executive Summary
Later this month, MEPs on the European Parliament's environment and public health committee will vote on proposed changes to Regulation (EC) No 726/2004, the key legislation governing the European Medicines Agency and the centralized drug approval procedure1,2.